Issue 11, 2011

Novel thalidomide analogues with potent NFκB and TNF expression inhibition

Abstract

A series of N-phenyl thalidomide analogues have been prepared efficiently through a Buchwald–Hartwig cross coupling reaction as the key step. Several of these compounds have extraordinary TNF expression inhibition compared to both thalidomide and the current pharmaceutical agent Revlimid (Lenalidomide).

Graphical abstract: Novel thalidomide analogues with potent NFκB and TNF expression inhibition

Supplementary files

Article information

Article type
Concise Article
Submitted
19 Jul 2011
Accepted
15 Aug 2011
First published
07 Sep 2011

Med. Chem. Commun., 2011,2, 1073-1078

Novel thalidomide analogues with potent NFκB and TNF expression inhibition

S. Y. Yeung, S. Kampmann, K. A. Stubbs, B. W. Skelton, B. J. Kaskow, L. J. Abraham and S. G. Stewart, Med. Chem. Commun., 2011, 2, 1073 DOI: 10.1039/C1MD00184A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements